Angelina Hatlø Maniaol

15.12.2025: A small subgroup of patients with myasthenia gravis experience severe muscle weakness and have a risk of respiratory failure despite receiving optimal standard therapy. Although new medications, including complement inhibitors and FcRn blockers, have well-documented clinical efficacy, they have not...